TRIM67

Chr 1

tripartite motif containing 67

Also known as: TNL

Predicted to enable zinc ion binding activity. Predicted to be involved in regulation of protein localization. Predicted to act upstream of or within negative regulation of Ras protein signal transduction; positive regulation of neuron projection development; and positive regulation of ubiquitin-dependent protein catabolic process. Predicted to be located in cytoskeleton. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
17
Pubs (1 yr)
P/LP submissions
P/LP missense
0.33
LOEUF· LoF intol.
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.33LOEUF
pLI 0.965
Z-score 4.21
OE 0.14 (0.070.33)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.74Z-score
OE missense 0.76 (0.700.84)
325 obs / 426.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.14 (0.070.33)
00.351.4
Missense OE?0.76 (0.700.84)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 4 / 28.1Missense obs/exp: 325 / 426.1Syn Z: -0.24

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TRIM67 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →